SEC SUMMIT 2026 | 10 SEPT | LONDON
A different kind of investor-founder event.
What attendees say
Truly one of the most refreshing and well-executed events I've attended recently! The format, energy, and openness made it easy to build genuine new connections — not just collect business cards.
This event was hands-down the best event I've been to since I've been in this CEO role… to come away with numerous decent leads for further conversation with investors is nothing short of amazing.
Excellent event! Open conversations at the Synapse roundtables which were much more interesting and useful than £2,000+ paid polished conference panels! Great networking environment and overall great execution.
The smaller group Synapse discussions on various topics were really insightful, you don't often have the opportunity to share different viewpoints so freely from both the Founder and Investor side.
40
founders
60%
investors
25+
Synapse roundtables
10+
activities
WHY?
Most founder and investor events are pretty forgettable.
Tired of endless pitching, the same panel discussions, rooms full of hard sell service providers and "investment" conferences with no investors present?
So are we. So we're building the kind of event we'd actually want to attend - a day designed for joy, passion and meaningful connection.
WHAT?
A day built for connection.
WHO?
Investors and founders, by invitation.
Designed exclusively for investors and founders across the life sciences — therapeutics, medical technologies, digital health, AI-native biology, AgriTech, ClimateTech and enabling tools and technologies. The audience is intentionally weighted towards investors, with roughly 60% investors and 40% founders. The result is a very different atmosphere from the typical event: better conversations and stronger relationships.
HOW CAN I JOIN?
We’re building the kind of event we’d actually want to attend.
A room full of thoughtful people. Interesting conversations. New ideas. New friendships. And hopefully a lot of fun.
If that sounds like your kind of day, we’d love to have you join us.
Investors: Secure a ticket directly below.
Founders: To keep the SEC Summit highly interactive and ensure every founder has the opportunity to build meaningful relationships with investors, attendance is intentionally limited and curated. This year we’ll be selecting 40 founders to attend: 15 Pre-Seed, 15 Seed and 10 Series A. Founders can apply for a spot below.
London | 10:30 – 20:00 | Exact details shared with confirmed attendees
Partnership opportunities
Sponsor the room you want to be in.
A very small number of sponsor slots are available on a first-come, first-served basis so attendees remain overwhelmingly investors and founders. Reach out early.
Enquire about partnership →Thank you to our partners
GOLD SPONSOR
British Land creates innovation-first spaces designed to help pioneering science and technology companies grow. Across its campuses, British Land brings together flexible labs and workspaces, vibrant communities and connections to collaborators, partners and investors.
GOLD SPONSOR
Winston Taylor is a transatlantic law firm supporting innovative life sciences and healthcare companies through complex legal, commercial and regulatory challenges. Its specialist team advises pharmaceutical, biotech, therapeutics and medical device companies across the investment lifecycle, including fundraising, M&A, governance, IP and high-stakes disputes.
SILVER SPONSOR
Marks & Clerk is a leading intellectual property firm with deep expertise across the life sciences. Their specialist team works with businesses from startups and university spinouts to global life science companies, helping them protect and maximise the value of innovations spanning therapeutics, diagnostics, biotechnology and more.
SILVER SPONSOR
Centre for Process Innovation (CPI) is a leading UK deep-tech innovation partner, helping companies turn ambitious ideas into commercially viable products and processes. Through multidisciplinary expertise and world-class facilities, CPI supports life science innovators across biotechnology, biologics, pharmaceuticals and HealthTech, from early R&D through process development and scale-up.
